338 related articles for article (PubMed ID: 26069211)
1. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
2. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenic risk of human induced pluripotent stem cell explants cultured on mouse SNL76/7 feeder cells.
Kamada M; Mitsui Y; Kumazaki T; Kawahara Y; Matsuo T; Takahashi T
Biochem Biophys Res Commun; 2014 Oct; 453(3):668-73. PubMed ID: 25305485
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
[TBL] [Abstract][Full Text] [Related]
6. Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.
Yu G; Okawa H; Okita K; Kamano Y; Wang F; Saeki M; Yatani H; Egusa H
J Dent Res; 2016 Jan; 95(1):110-8. PubMed ID: 26467419
[TBL] [Abstract][Full Text] [Related]
7. Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
Bedel A; Beliveau F; Lamrissi-Garcia I; Rousseau B; Moranvillier I; Rucheton B; Guyonnet-Dupérat V; Cardinaud B; de Verneuil H; Moreau-Gaudry F; Dabernat S
Stem Cells Transl Med; 2017 Feb; 6(2):382-393. PubMed ID: 28191782
[TBL] [Abstract][Full Text] [Related]
8. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
9. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
10. Retinol (vitamin A) maintains self-renewal of pluripotent male germline stem cells (mGSCs) from adult mouse testis.
Zhang S; Sun J; Pan S; Zhu H; Wang L; Hu Y; Wang J; Wang F; Cao H; Yan X; Hua J
J Cell Biochem; 2011 Apr; 112(4):1009-21. PubMed ID: 21308744
[TBL] [Abstract][Full Text] [Related]
11. Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.
Liu CC; Ma DL; Yan TD; Fan X; Poon Z; Poon LF; Goh SA; Rozen SG; Hwang WY; Tergaonkar V; Tan P; Ghosh S; Virshup DM; Goh EL; Li S
Stem Cells; 2016 Oct; 34(10):2471-2484. PubMed ID: 27299710
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
[TBL] [Abstract][Full Text] [Related]
13. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.
Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N
Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368
[TBL] [Abstract][Full Text] [Related]
14. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
[TBL] [Abstract][Full Text] [Related]
15. Isolation of three stem cell lines from human sacrococcygeal teratomas.
Busch C; Bareiss PM; Sinnberg T; Just L; Wehrmann M; Fuchs J; Garbe C; Drews U
J Pathol; 2009 Mar; 217(4):589-96. PubMed ID: 19142973
[TBL] [Abstract][Full Text] [Related]
16. Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential.
Vaags AK; Rosic-Kablar S; Gartley CJ; Zheng YZ; Chesney A; Villagómez DA; Kruth SA; Hough MR
Stem Cells; 2009 Feb; 27(2):329-40. PubMed ID: 19038794
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
18. Late passage human fibroblasts induced to pluripotency are capable of directed neuronal differentiation.
Liu J; Sumer H; Leung J; Upton K; Dottori M; Pébay A; Verma PJ
Cell Transplant; 2011; 20(2):193-203. PubMed ID: 20719071
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of deviation from the undifferentiated state in colonies of human induced pluripotent stem cells on feeder layers.
Kim MH; Masuda E; Kino-oka M
Biotechnol Bioeng; 2014 Jun; 111(6):1128-38. PubMed ID: 24420640
[TBL] [Abstract][Full Text] [Related]
20. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
du Puy L; Lopes SM; Haagsman HP; Roelen BA
Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
